SCM
OLMA icon

Sterling Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Sterling Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$34.5K Sell
2,314
-1,127
-33% -$25.1K ﹤0.01% 1787
2025
Q4 		$86K Sell
3,441
-668
-16% -$11.9K ﹤0.01% 1596
2025
Q3 		$40.2K Buy
4,109
+2,501
+156% +$15K ﹤0.01% 1837
2025
Q2 		$6.85K Buy
1,608
+1,053
+190% +$4.7K ﹤0.01% 2344
2025
Q1 		$2.09K Sell
555
-461
-45% -$2.32K ﹤0.01% 2581
2024
Q4 		$5.92K Buy
1,016
+911
+868% +$9.1K ﹤0.01% 2381
2024
Q3 		$1.25K Buy
+105
New +$1.34K ﹤0.01% 2414

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Sterling Capital Management's OLMA Position: Q1 2026 in Review

Sterling Capital Management reduced its Olema Pharmaceuticals (OLMA) stake by 33% in Q1 2026, selling an estimated $25.1K and leaving 2,314 shares worth $34.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1787.

Sterling Capital Management first reported a position in OLMA in Q3 2024 and has held it in 7 quarters since. The position peaked at $86K in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Sterling Capital Management held 2,314 shares of Olema Pharmaceuticals worth $34.5K as of Q1 2026.
  • Sterling Capital Management sold 1,127 Olema Pharmaceuticals shares in Q1 2026, an estimated $25.1K.
  • Olema Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #1787 holding.
  • Sterling Capital Management first reported a position in Olema Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Olema Pharmaceuticals position peaked at $86K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.